Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4322.45 | 1445 / 1445 | 100% | 28.04 | 183 / 183 |
lung | 100% | 4038.39 | 578 / 578 | 100% | 25.21 | 1155 / 1155 |
ovary | 100% | 3627.49 | 180 / 180 | 100% | 16.01 | 430 / 430 |
breast | 100% | 3818.72 | 459 / 459 | 100% | 25.51 | 1116 / 1118 |
bladder | 100% | 3824.38 | 21 / 21 | 100% | 24.16 | 503 / 504 |
prostate | 100% | 3358.67 | 245 / 245 | 99% | 19.98 | 499 / 502 |
brain | 100% | 2739.77 | 2629 / 2642 | 100% | 22.71 | 704 / 705 |
uterus | 100% | 3802.15 | 170 / 170 | 99% | 20.44 | 456 / 459 |
stomach | 100% | 2617.57 | 359 / 359 | 99% | 25.82 | 284 / 286 |
intestine | 100% | 3729.09 | 966 / 966 | 99% | 23.35 | 523 / 527 |
thymus | 100% | 3483.20 | 653 / 653 | 99% | 18.98 | 598 / 605 |
pancreas | 100% | 1977.24 | 327 / 328 | 99% | 20.06 | 176 / 178 |
liver | 100% | 3537.16 | 226 / 226 | 99% | 15.11 | 400 / 406 |
kidney | 100% | 2517.44 | 89 / 89 | 98% | 19.55 | 884 / 901 |
adrenal gland | 100% | 3195.13 | 258 / 258 | 95% | 12.87 | 219 / 230 |
skin | 100% | 4205.58 | 1809 / 1809 | 95% | 19.86 | 449 / 472 |
adipose | 100% | 4085.88 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3964.96 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.16 | 29 / 29 |
muscle | 100% | 2940.38 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3384.48 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.48 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.29 | 1 / 1 |
peripheral blood | 98% | 3375.51 | 913 / 929 | 0% | 0 | 0 / 0 |
heart | 96% | 2289.72 | 829 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 6.97 | 55 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0031623 | Biological process | receptor internalization |
GO_0006954 | Biological process | inflammatory response |
GO_0001558 | Biological process | regulation of cell growth |
GO_0045087 | Biological process | innate immune response |
GO_0035739 | Biological process | CD4-positive, alpha-beta T cell proliferation |
GO_0051607 | Biological process | defense response to virus |
GO_0060544 | Biological process | regulation of necroptotic process |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0032480 | Biological process | negative regulation of type I interferon production |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_2000646 | Biological process | positive regulation of receptor catabolic process |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0002870 | Biological process | T cell anergy |
GO_0050687 | Biological process | negative regulation of defense response to virus |
GO_1902036 | Biological process | regulation of hematopoietic stem cell differentiation |
GO_0046329 | Biological process | negative regulation of JNK cascade |
GO_0090085 | Biological process | regulation of protein deubiquitination |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_0006915 | Biological process | apoptotic process |
GO_0002669 | Biological process | positive regulation of T cell anergy |
GO_0039532 | Biological process | negative regulation of cytoplasmic pattern recognition receptor signaling pathway |
GO_0006513 | Biological process | protein monoubiquitination |
GO_0035519 | Biological process | protein K29-linked ubiquitination |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0035872 | Biological process | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
GO_2000562 | Biological process | negative regulation of CD4-positive, alpha-beta T cell proliferation |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005769 | Cellular component | early endosome |
GO_0031901 | Cellular component | early endosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0016874 | Molecular function | ligase activity |
GO_0019787 | Molecular function | ubiquitin-like protein transferase activity |
GO_0043021 | Molecular function | ribonucleoprotein complex binding |
GO_1990763 | Molecular function | arrestin family protein binding |
GO_0045236 | Molecular function | CXCR chemokine receptor binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0044389 | Molecular function | ubiquitin-like protein ligase binding |
Gene name | ITCH |
Protein name | E3 ubiquitin-protein ligase Itchy homolog (Itch) (EC 2.3.2.26) (Atrophin-1-interacting protein 4) (AIP4) (HECT-type E3 ubiquitin transferase Itchy homolog) (NFE2-associated polypeptide 1) (NAPP1) Itchy E3 ubiquitin protein ligase E3 ubiquitin-protein ligase (EC 2.3.2.26) E3 ubiquitin-protein ligase Itchy homolog |
Synonyms | |
Description | FUNCTION: Acts as an E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates . Catalyzes 'Lys-29'-, 'Lys-48'- and 'Lys-63'-linked ubiquitin conjugation . Involved in the control of inflammatory signaling pathways . Essential component of a ubiquitin-editing protein complex, comprising also TNFAIP3, TAX1BP1 and RNF11, that ensures the transient nature of inflammatory signaling pathways . Promotes the association of the complex after TNF stimulation . Once the complex is formed, TNFAIP3 deubiquitinates 'Lys-63' polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains . This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NFKB1 . Ubiquitinates RIPK2 by 'Lys-63'-linked conjugation and influences NOD2-dependent signal transduction pathways . Regulates the transcriptional activity of several transcription factors, and probably plays an important role in the regulation of immune response . Ubiquitinates NFE2 by 'Lys-63' linkages and is implicated in the control of the development of hematopoietic lineages . Mediates JUN ubiquitination and degradation (By similarity). Mediates JUNB ubiquitination and degradation . Critical regulator of type 2 helper T (Th2) cell cytokine production by inducing JUNB ubiquitination and degradation (By similarity). Involved in the negative regulation of MAVS-dependent cellular antiviral responses . Ubiquitinates MAVS through 'Lys-48'-linked conjugation resulting in MAVS proteasomal degradation . Following ligand stimulation, regulates sorting of Wnt receptor FZD4 to the degradative endocytic pathway probably by modulating PI42KA activity . Ubiquitinates PI4K2A and negatively regulates its catalytic activity . Ubiquitinates chemokine receptor CXCR4 and regulates sorting of CXCR4 to the degradative endocytic pathway following ligand stimulation by ubiquitinating endosomal sorting complex required for transport ESCRT-0 components HGS and STAM . Targets DTX1 for lysosomal degradation and controls NOTCH1 degradation, in the absence of ligand, through 'Lys-29'-linked polyubiquitination . Ubiquitinates SNX9 . Ubiquitinates MAP3K7 through 'Lys-48'-linked conjugation (By similarity). Involved in the regulation of apoptosis and reactive oxygen species levels through the ubiquitination and proteasomal degradation of TXNIP . Mediates the antiapoptotic activity of epidermal growth factor through the ubiquitination and proteasomal degradation of p15 BID . Ubiquitinates BRAT1 and this ubiquitination is enhanced in the presence of NDFIP1 . Inhibits the replication of influenza A virus (IAV) via ubiquitination of IAV matrix protein 1 (M1) through 'Lys-48'-linked conjugation resulting in M1 proteasomal degradation . Ubiquitinates NEDD9/HEF1, resulting in proteasomal degradation of NEDD9/HEF1 . . |
Accessions | ENST00000461661.2 ENST00000665484.2 A0A8V8TKK4 ENST00000665346.1 [Q96J02-1] ENST00000665428.1 A0A590UIY0 ENST00000535650.8 [Q96J02-3] ENST00000670516.1 A0A590UK95 ENST00000660337.1 ENST00000696974.1 [Q96J02-2] Q96J02 ENST00000374864.10 [Q96J02-2] A0A590UJW8 ENST00000696975.1 ENST00000696985.1 A0A590UJQ1 A0A590UK44 A0A8V8TKI4 ENST00000262650.11 [Q96J02-1] ENST00000664852.1 A0A1W2PNZ8 A0A590UJ55 ENST00000696981.1 ENST00000654846.1 ENST00000696978.1 |